Imunon, Inc. Shareholders' Equity
Imunon, Inc. (IMNN) had Shareholders' Equity of $4.19 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-11
- 2026-06-30: Stockholders' Equity Attributable to Parent $4.19M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $3.36M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $7.06M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $4.08M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $4.19M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $3.36M 10-Q · filed 2026-08-11 |
| 2025-12-31 | $7.06M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $4.08M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $2.66M 10-Q · filed 2026-08-11 |
| 2025-03-31 | $452.03K 10-Q · filed 2026-08-11 |
| 2024-12-31 | $4.24M 10-Q · filed 2026-08-11 |
| 2024-09-30 | $8.19M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $3.74M 10-Q · filed 2025-11-13 |
| 2024-03-31 | $8.50M 10-Q · filed 2025-08-05 |
| 2023-12-31 | $13.39M 10-K · filed 2026-03-31 |
| 2023-09-30 | $18.07M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $21.52M 10-Q · filed 2024-11-07 |
| 2023-03-31 | $26.65M 10-Q · filed 2024-08-14 |
| 2022-12-31 | $29.33M 10-K · filed 2025-02-27 |
| 2022-09-30 | $41.35M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $47.04M 10-Q · filed 2023-11-14 |
| 2022-03-31 | $46.27M 10-Q · filed 2023-08-10 |
| 2021-12-31 | $55.80M 10-K · filed 2024-03-28 |
| 2021-09-30 | $59.34M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $64.05M 10-Q · filed 2022-11-14 |
| 2021-03-31 | $54.96M 10-Q · filed 2022-08-15 |
| 2020-12-31 | $18.61M 10-K · filed 2023-03-30 |
| 2020-09-30 | $18.66M 10-Q · filed 2021-11-15 |
| 2020-06-30 | $24.21M 10-Q · filed 2021-11-15 |
| 2020-03-31 | $16.21M 10-Q · filed 2021-08-12 |
| 2019-12-31 | $14.56M 10-K · filed 2022-03-31 |
| 2019-09-30 | $15.46M 10-Q · filed 2020-11-16 |
| 2019-06-30 | $18.83M 10-Q · filed 2020-11-16 |
| 2019-03-31 | $21.40M 10-Q · filed 2020-08-14 |
| 2018-12-31 | $20.86M 10-K · filed 2021-03-19 |
| 2018-09-30 | $15.13M 10-Q · filed 2019-11-14 |
| 2018-06-30 | $19.15M 10-Q · filed 2019-11-14 |
| 2018-03-31 | $23.61M 10-Q · filed 2019-08-14 |
| 2017-12-31 | $26.70M 10-K · filed 2020-03-25 |
| 2017-09-30 | $5.29M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $6.65M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $6.11M 10-Q · filed 2017-05-12 |
| 2016-12-31 | $6.73M 10-K · filed 2019-03-29 |
| 2016-09-30 | $10.57M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $16.51M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $15.31M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $20.39M 10-K · filed 2018-03-27 |
| 2015-09-30 | $25.08M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $29.11M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $26.70M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $32.83M 10-K · filed 2017-03-24 |
| 2014-09-30 | $38.92M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $45.36M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $40.56M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $31.52M 10-K · filed 2016-03-30 |
| 2013-09-30 | $29.14M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $32.99M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $32.30M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $11.96M 10-K · filed 2016-03-30 |
| 2012-09-30 | $13.02M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $14.58M 10-Q · filed 2012-08-14 |
| 2012-03-31 | $20.36M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $26.19M 10-K · filed 2015-03-12 |
| 2011-09-30 | $18.26M 10-Q · filed 2011-11-10 |
| 2011-06-30 | $489.41K 10-Q · filed 2011-08-09 |
| 2011-03-31 | -$5.04M 10-Q · filed 2012-05-15 |
| 2010-12-31 | -$4.58M 10-K · filed 2014-03-13 |
| 2009-12-31 | $10.04M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |